Valneva SE is a specialty vaccine company that ... It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived ...

Valneva's Ixchiq is the first and only approved ... For instance, VALN has travel vaccines like Ixiaro and Dukoral for Japanese encephalitis and cholera, respectively. Still, the main positive ...

In a report released on January 31, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva (0OB3 – Research ... and the second (DUKORAL) for the prevention of cholera and diarrhoea.

While much of Valneva's focus these days is centered on its landmark vaccine for chikungunya virus, the French immunization specialist's catalog of older shots continues to serve up fresh governmen | ...

H.C. Wainwright analyst Edward White reiterated a Buy rating on Valneva (VALN – Research ... and the second (DUKORAL) for the prevention of cholera and diarrhoea. The segments of the group ...

Valneva (NASDAQ:VALN) ADRs traded higher in the premarket on Tuesday after the French biotech posted additional data for its FDA-approved chikungunya vaccine, Ixchiq, from a Phase 3 trial for ...